Narnolia

Narnolia

Toll Free No: 1800-103-7212

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE223.952.35 (+1.06 %)
PREV CLOSE ( ) 221.60
OPEN PRICE ( ) 224.40
BID PRICE (QTY) 224.00 (10)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 202136
TODAY'S LOW / HIGH ( )215.20 225.15
52 WK LOW / HIGH ( )211.3 359.18
NSE224.152.25 (+1.01 %)
PREV CLOSE( ) 221.90
OPEN PRICE ( ) 222.00
BID PRICE (QTY) 224.15 (1680)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4049142
TODAY'S LOW / HIGH( ) 215.05 225.20
52 WK LOW / HIGH ( )211.05 359
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 29-11 1978
Management Info
Kiran Mazumdar-Shaw - Chairman Kiran Mazumdar-Shaw - Managing Director
Registered Office

Address 20th Km,Hosur Road,Electronic City,
Bengaluru,
Karnataka-560100

Phone 080 2808 2808

Email corporate.communications@biocon.com

Website www.biocon.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
22Aug Biocon’s arm receives certificate of G
Biocon’s subsidiary -- Biocon Sdn. Bhd., Malaysia, which operates Asia’s..
22Aug Biocon submits press release
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure..
08Aug Biocon informs about analyst meet
Biocon has informed that meetings were conducted with Institutional Inve..
01Aug Biocon, Mylan launch Ogivri in Australia
Biocon and Mylan have launched First Trastuzumab Biosimilar, Ogivri in A..
26Jul Biocon reports 72% rise in Q1 consolid
Biocon has reported results for first quarter ended June 30, 2019.The co..
Financials
Rs. in Millions
QTR Jun 19 ANNUAL 19
Net Profit11194927
Gross Profit 1562 5521
Operating Profit 9875031
Net Sales 480828847
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
peergroup  6032.65 (1.46%)
M.Cap ( in Cr)13893.57
Astrazeneca Pharma I (BSE)
peergroup  1746.40 (4.12%)
M.Cap ( in Cr)4366.00
Piramal Enterprises (BSE)
peergroup  1781.40 (3.23%)
M.Cap ( in Cr)35422.53
Abbott India (BSE)
peergroup  8786.90 (0.61%)
M.Cap ( in Cr)18671.55
Alkem Laboratories (BSE)
peergroup  1771.30 (1.21%)
M.Cap ( in Cr)21178.55
Shareholding Pattern
PROMOTERS 60.67%
MUTUAL FUNDS/UTI 3.01%
NON-INSTITUTION 18.61%
FI/BANKS/INSURANCE 1.26%
GOVERNMENT 0%
FII 0%
About Biocon Ltd.

Biocon Ltd. was incorporated in the year 29-11-1978. Its today's share price is 223.95. Its current market capitalisation stands at Rs 26874 Cr. In the latest quarter, company has reported Gross Sales of Rs. 55144 Cr and Total Income of Rs.56588 Cr. The company's management includes Mayank Verma, Vijay Kuchroo, Daniel M Bradbury, Jeremy Levin, John Shaw, Bobby Parikh, Russell Walls, M Damodaran, Ravi Mazumdar, Mary Harney, Kiran Mazumdar-Shaw, Kiran Mazumdar-Shaw, Arun Chandavarkar.

It is listed on the BSE with a BSE Code of 532523 , NSE with an NSE Symbol of BIOCON and ISIN of INE376G01013. It's Registered office is at 20th Km,Hosur Road,Electronic CityBengaluru-560100, Karnataka. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP

Directory

current IPO
  • --
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room